Cardiol Therapeutics Inc Class A faced a significant decline in its stock price, raising concerns among investors.
In yesterday's trading session, Cardiol Therapeutics Inc Class A (CRDL.TO) saw its stock price drop by 12.34%, closing at CA$2.77. This sharp decline has left investors questioning the company's stability and future prospects.
Advertisement
Cardiol Therapeutics Inc Class A
CRDL.TO
CRDL.TO
Cardiol Therapeutics Inc Class A
WealthAwesomeMarket cap
$369.16M
52W high
$3.23
52W low
$1.23
1W change
-7.05%
Beta
0.61
Analyst Price Targets
Based on analyst covering CRDL
Wall Street analysts forecast CRDL stock price to rise 116.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+116.6% Upside
Current Price
C$2.77
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRDL's historical volatility
30-Day Vol
80.6%
Annualized
90-Day Vol
61.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$3.31
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.94 | C$2.23 โ C$3.88 |
| 60 trading days | C$3.12 | C$2.11 โ C$4.62 |
| 90 trading days | C$3.31 | C$2.05 โ C$5.36 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should closely monitor Cardiol Therapeutics as the recent drop in stock price may indicate underlying issues or shifts in market sentiment.
12.34% decline in stock price
Cardiol Therapeutics Inc Class A's market cap now stands at CA$369 million, a significant drop from previous valuations.
Bull case
Despite the recent downturn, Cardiol Therapeutics is actively engaging with investors and participating in major conferences. These efforts could enhance its visibility and attract future investment.
Bear case
The 12.34% drop in stock price reflects investor concerns about the company's performance and potential challenges ahead, especially given the lack of recent positive news.
Recent Performance Overview
Advertisement
Cardiol Therapeutics faced a challenging trading day yesterday, with its stock price falling by 12.34%. This decline raises questions about investor confidence and the company's current standing in the market. The drop in share price has brought the market cap down to CA$369 million, highlighting the volatility often seen in smaller biotech firms.
Market Sentiment and Future Outlook
The lack of recent positive news from Cardiol Therapeutics could be contributing to the negative sentiment surrounding the stock. Investors are urged to consider the implications of this drop and to stay informed about any upcoming announcements or developments that could influence the company's trajectory. Historically, biotech stocks can be highly reactive to news, making it crucial for investors to monitor the situation closely.
What Investors Should Watch For
As Cardiol Therapeutics navigates this downturn, investors should keep an eye on any future presentations or data releases that could shift market sentiment. The company's participation in events like the H.C. Wainwright 28th Annual Global Investment Conference may provide opportunities for recovery, but caution is advised given the current volatility. For more insights, check out the Cardiol Therapeutics stock page for updates.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
